Prezentacje ustne
P. Spisz, M. Zdrowowicz, S. Makurat, W. Kozak, K. Skotnicki, K. Bobrowski , J. Rak
Why does the type of halogen atom matter for radiosensitizing properties of 5-substituted 4-thio-2’-deoxyuridines?
2nd Molecules Medicinal Chemistry Symposium „Facing Novel Challenges in Drug Discovery”, Barcelona, Hiszpania, 15-17.05.2019
Prezentacje posterowe
S. Makurat, M. Zdrowowicz, P. Spisz, W. Kozak, J. Rak
5-Iodo-4-thio-2’-deoxyuridine as an X-ray Sensitizer
Medicinal Chemistry Residential School; Loughborough, Wielka Brytania; 2-7.06.2019
K. Falkiewicz, W. Kozak, J. Rak
Can 6-substituted pyrimidine nucleosides sensitize DNA to damage induced by ionizing radiation?
7th International Conference on Radiation in Various Fields of Research; Herceg Novi, Czarnogóra; 10-14.06.2019
E. Arthur-Baidoo, J. Ameixa, R. Meißner, S. Makurat, W. Kozak, F. Ferreira da Silva, J. Rak, S. Denifl
Dissociative Electron Attachment to 5–trifluoromethanesulfonyl-uracil
XXXIst International Conference on Photonic, Electronic and Atomic Collisions (ICPEAC 2019); Deauville, Francja; 23-30.07.2019
M. Zdrowowicz, S. Makurat, P. Spisz, W. Kozak, J. Rak
5-Iodo-4-Thio-2′-Deoxyuridine as a Sensitizer of X-Ray Induced Cancer Cell Killing
6th EFMC Young Medicinal Chemist Symposium; Ateny, Grecja; 5-6.09.2019
P. Spisz, M. Zdrowowicz, S. Makurat, W. Kozak, J. Rak
Is the 5-Bromo-4-Thio-2′-Deoxyuridine a Potential Radiosensitizer of DNA Damage?
6th EFMC Young Medicinal Chemist Symposium; Ateny, Grecja; 5-6.09.2019